000 | 01930 a2200601 4500 | ||
---|---|---|---|
005 | 20250518030824.0 | ||
264 | 0 | _c20200305 | |
008 | 202003s 0 0 eng d | ||
022 | _a1872-8332 | ||
024 | 7 |
_a10.1016/j.lungcan.2019.02.022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHermans, B C M | |
245 | 0 | 0 |
_aPrevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC). _h[electronic resource] |
260 |
_bLung cancer (Amsterdam, Netherlands) _c04 2019 |
||
300 |
_a179-186 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aB7-H1 Antigen _xgenetics |
650 | 0 | 4 | _aCD8 Antigens |
650 | 0 | 4 |
_aCarcinoma, Large Cell _xdiagnosis |
650 | 0 | 4 |
_aCarcinoma, Neuroendocrine _xdiagnosis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNetherlands _xepidemiology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPopulation Groups |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aDerks, J L | |
700 | 1 | _aThunnissen, E | |
700 | 1 | _avan Suylen, R J | |
700 | 1 | _aden Bakker, M A | |
700 | 1 | _aGroen, H J M | |
700 | 1 | _aSmit, E F | |
700 | 1 | _aDamhuis, R A | |
700 | 1 | _avan den Broek, E C | |
700 | 1 | _aStallinga, C M | |
700 | 1 | _aRoemen, G M | |
700 | 1 | _aSpeel, E J M | |
700 | 1 | _aDingemans, A-M C | |
773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 130 _gp. 179-186 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lungcan.2019.02.022 _zAvailable from publisher's website |
999 |
_c29491094 _d29491094 |